System1 Biosciences Company
System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. System1 combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. These “deep phenotypes” are exploited to identify novel therapeutic targets and drug treatments.
Investors
Founded Date:
2017-01-01
Last Funding Date:
2018-09-12
Industry:
Quantum Biology
Total Funding:
25000000
Headquarters:
San Francisco,California,United States,North America
Employee Number:
10001+
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
25000000
Last Funding Total Usd:
25000000
Last Funding Total Currency:
USD
Last Funding Total Value:
25000000
Founders:
Frederic Kerrest,Saul Kato,Sean Escola